Bruce Lyday is CEO and co-founder of Coronavax, Inc., a Biotechnology Company located in Orange, CA. Coronavax is developing CVAX-001, a new immunotherapeutic for Long COVID. Mr. Lyday has been a researcher in the fields of immunology, virology, oncology, and cell biology. Mr. Lyday has multiple patents and one Investigational New Drug (IND), approval for a novel cancer therapy. Mr. Lyday has successfully negotiated agreements with the U.S. Army at USAMMDA-Ft. Detrick, MD, and the Centers for Disease Control for use of their virus strains to treat cancer.
Archives: Speakers
Kay Olmstead
Darren LaCour
A biomedical product development professional experienced with GMP, GLP, and GCP requirements for products seeking U.S. regulatory approval. My primary experience encompasses the design and execution of clinical trials with oversight of clinical data input through the phases of Endovascular products development life cycle. I transitioned to the clinical research industry after being a Pharmaceutical Chemist for several years.
Constance Crowley
Elizabeth Sheehan, PMP
Experienced project management professional with a strong background in medical device clinical trials. Elizabeth is currently a Sr. Clinical Project Manager at Recor Medical, a medical device company located in Palo Alto, California. Previous work experience includes knowledge manager at a big three strategy consulting firm, and archivist at UCLA organizing, preserving, and providing access to collection materials.
Khatija Ali
As CEO & Founder of BioSapien, Khatija Ali MD is dedicated to transforming patient care with the MediChip, focusing on local cancer treatment. With over 4 years of experience in venture capital and private equity, Khatija specializes in diligence, capital raising, and portfolio management across biotech. She is recognized for her networking skills and philanthropic efforts. Recognitions include Meet The Drapers competition, the Startup Prize and Top 25 CEOs in Biotech. Outside of work, Khatija enjoys outdoor activities and racing cars.
Eric Pittman
Eric Pittman currently serves as the Program Division Director (PDD) for the Bioresearch Monitoring Division II (BIMO-W) staff. As the PDD, he provides leadership in directing and managing programs and a professional staff in locations from Detroit, MI to Hawaii covering all clinical and non-clinical facilities. In addition to being the PDD for BIMO-W, Eric is one of the U.S. Representatives to the Organization for Economic Co-Operation and Development (OECD).
Supplement to his work experience with the FDA, Eric has worked in the Medical Device, Food and Drug Industries serving in various capacities such as a Regulatory Affairs Associate and Director of Quality.
Eric attended Purdue University School of Pharmacy and while there also earned a degree in radiation physics. He has an MBA from Youngstown State University along with several certifications for various quality and regulatory activities.
Monica Stancu
Monica Stancu leads the Diversity and Inclusion work at Lloyd’s, the world’s biggest insurance and reassurance marketplace. Previously, she has worked in diversity and inclusion at the Royal Academy of Engineering, Sodexo and F. Hoffman La Roche.
Monica has also worked in international affairs and human rights at the European Medicines Agency (EU agency) and the United Nations. She is the author of the book “Building Diversity and Inclusion: From Commitment to Action.”
She holds an MA in Women’s History from Sarah Lawrence College, USA and was a visiting scholar at the Institute for Research on Women, Gender and Sexuality at Columbia University in the City of New York.
Monica has been selected as a Global Champion for Women’s Economic Empowerment by UN Women, has won a WeAreTheCity 2020 Rising Stars award and has been listed as a 2023 and 2022 D&I Inspirational leader by D&I Leaders. She is also a One Young World Ambassador and a mentor at Migrant Leaders.